Cargando…
Assessment of Growth Reduction of Five Clinical Pathogens by Injectable S53P4 Bioactive Glass Material Formulations
The one-stage treatment of chronic osteomyelitis with S53P4 bioactive glass (BAG) granules has shown excellent results. However, these granules possess suboptimal handling properties. Therefore, new injectable S53P4 putty materials have been developed by the incorporation of a synthetic binder to co...
Autores principales: | Thijssen, Eline G. J., van Gestel, Nicole A. P., Bevers, Raymond, Hofmann, Sandra, Geurts, Jan, van Loo, Inge H. M., Arts, J. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333246/ https://www.ncbi.nlm.nih.gov/pubmed/32676498 http://dx.doi.org/10.3389/fbioe.2020.00634 |
Ejemplares similares
-
Cost-Effectiveness Study of One-Stage Treatment of Chronic Osteomyelitis with Bioactive Glass S53P4
por: Geurts, Jan, et al.
Publicado: (2019) -
Clinical Applications of S53P4 Bioactive Glass in Bone Healing and Osteomyelitic Treatment: A Literature Review
por: van Gestel, N. A. P., et al.
Publicado: (2015) -
Bioactive Glasses: Frontiers and Challenges
por: Hench, Larry L., et al.
Publicado: (2015) -
Using Bioactive Glasses in the Management of Burns
por: Kargozar, Saeid, et al.
Publicado: (2019) -
Alginate-modified mesoporous bioactive glass and its drug delivery, bioactivity, and osteogenic properties
por: Yao, Haiyan, et al.
Publicado: (2022)